Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne Vulgaris

PHASE4CompletedINTERVENTIONAL

Enrollment

171

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Acne Vulgaris

Interventions

DRUG

Dapsone

Dapsone topical gel 5%, 1 pea-size amount BID x 12 weeks and Tazarotene Cream 0.1%, 1 pea-size amount QD x 12 weeks

DRUG

Tazarotene

Tazarotene Cream 0.1%, 1 pea-size amount QD x 12 weeks

Trial Locations (1)

Fremont